Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
Authors:
Open Access
- 21 July 2022
- journal article
- research article
- Published by Elsevier in Neurotherapeutics
- Vol. 19 (5) , 1662-1685
Abstract
No abstract availableKeywords
Funding Information
- University of Melbourne
This publication has 102 references indexed in Scilit:
- A role for the extended amygdala in the fear-enhancing effects of acute selective serotonin reuptake inhibitor treatmentTranslational Psychiatry, 2013
- How the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structureTranslational Psychiatry, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of ResearchPsychosomatic Medicine, 2011
- The Modulatory Role of the Lateral Septum on Neuroendocrine and Behavioral Stress ResponsesNeuropsychopharmacology, 2010
- Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypesProceedings of the National Academy of Sciences, 2009
- Unconditioned stimulus pathways to the amygdala: Effects of lesions of the posterior intralaminar thalamus on foot-shock-induced c-Fos expression in the subdivisions of the lateral amygdalaNeuroscience, 2008
- Acute Selective Serotonin Reuptake Inhibitors Increase Conditioned Fear Expression: Blockade With a 5-HT2C Receptor AntagonistBiological Psychiatry, 2007
- Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats☆Behavioural Brain Research, 2006
- Modularity and community structure in networksProceedings of the National Academy of Sciences of the United States of America, 2006